Recently, Musk’s neurotechnology company, the world’s richest man, announced that it will launch a "human trial" for the first time in 2022 to test the performance of human implanted chips developed by the company.
Musk disclosed in an online entrepreneurs summit that trial participants may be patients who have suffered severe spinal injuries, quadriplegia, and are unable to take care of themselves.
Musk said that the company has conducted many tests on the chip implantation operation and is currently able to ensure the safety and reliability of the product.
In April of this year, the company's related experiments have achieved certain results on macaques, and the test animals can use this "black technology" to operate simple computer games.
Currently, the company only needs to wait for approval from the U.S. Food and Drug Administration (FDA).
It is understood that this company, founded in 2016, aims to achieve "brain-computer integration", and its ultimate goal is to perfectly integrate human consciousness with machine intelligence.
The company's early work will focus on medical applications of human chips.
However, the company's animal experiments and planned human experiments have caused many moral and ethical controversies.
(Making Yueziyan)
Editor in charge: 【Luo Pan】